Market Place
Sourcing Support
Mirum Pharma announces positive CHMP opinion for Livmarli oral solution
03 Jun 2024 //
PHARMABIZ
US FDA approves expanded use of Mirum`s liver disease drug
14 Mar 2024 //
REUTERS
Mirum’s LIVMARLI® Now Authorized in Canada for Cholestatic Pruritus
25 Jul 2023 //
BUSINESSWIRE
Mirum Pharmaceuticals` Livmarli (Maralixibat chloride) Approved In Europe
05 Jul 2023 //
EMA
Data from Mirum’s LIVMARLI Studies Presented at ESPGHAN Annual Meeting
19 May 2023 //
BUSINESSWIRE
Hepatology Publishes Data from Mirum’s LIVMARLI in Sclerosing Cholangitis
18 May 2023 //
BUSINESSWIRE
Mirum Submits for European Approval of LIVMARLI
05 Apr 2023 //
BUSINESSWIRE
Mirum Pharma Submits Supplemental New Drug Application to FDA for LIVMARLI
14 Feb 2023 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.